| LDL-C/HDL-C Tertile | HR per 0.5 increased | |||||
---|---|---|---|---|---|---|---|
T1 | T2 | T3 | |||||
CVD mortality | |||||||
 Event rate, % | 13.0 | 13.8 | 18.9 | 15.2 | |||
 Events/total | 70/539 | 74/538 | 102/539 | 246/1616 | |||
HR (95% CI), P-value | |||||||
 Unadjusted | 1 [reference] | 1.113 (0.802–1.543) | 0.522 | 1.689 (1.244–2.291) | 0.001 | 1.112 (1.056–1.171) | < 0.001 |
 Model 1 | 1 [reference] | 1.079 (0.777–1.496) | 0.651 | 1.471 (1.084–1.998) | 0.013 | 1.087 (1.027–1.150) | 0.004 |
 Model 2 | 1 [reference] | 1.121 (0.805–1.561) | 0.498 | 1.476 (1.079–2.018) | 0.015 | 1.079 (1.018–1.144) | 0.010 |
 Model 3 | 1 [reference] | 1.338 (0.901–1.987) | 0.149 | 1.732 (1.191–2.518) | 0.004 | 1.110 (1.037–1.188) | 0.003 |
 Model 4 | 1 [reference] | 1.423 (0.954–2.122) | 0.084 | 1.880 (1.280–2.760) | 0.001 | 1.123 (1.049–1.202) | 0.001 |
All-cause mortality | |||||||
 Event rate, % | 28.6 | 27.0 | 35.8 | 30.4 | |||
 Events/total | 154/539 | 145/538 | 193/539 | 492/1616 | |||
HR (95% CI), P-value | |||||||
 Unadjusted | 1 [reference] | 0.994 (0.792–1.247) | 0.958 | 1.462 (1.182–1.808) | 0.001 | 1.099 (1.058–1.142) | < 0.001 |
 Model 1 | 1 [reference] | 0.952 (0.759–1.195) | 0.673 | 1.255 (1.014–1.552) | 0.037 | 1.070 (1.027–1.115) | 0.001 |
 Model 2 | 1 [reference] | 0.984 (0.782–1.237) | 0.887 | 1.248 (1.004–1.553) | 0.046 | 1.065 (1.020–1.110) | 0.004 |
 Model 3 | 1 [reference] | 1.077 (0.817–1.420) | 0.597 | 1.318 (1.010–1.721) | 0.042 | 1.073 (1.018–1.131) | 0.009 |
 Model 4 | 1 [reference] | 1.094 (0.828–1.446) | 0.529 | 1.345 (1.026–1.765) | 0.032 | 1.077 (1.021–1.136) | 0.006 |